Share capital [Text Block] | 8 Share capital Authorized: unlimited common shares, no par value Number of shares Ascribed value November 30, 2013 53,066,656 104,895 Exercise of NovaGold Arrangement Options 46,929 631 NovaGold Performance Share Units 14,166 28 Private placement 6,521,740 5,068 Restricted Share Units 492,501 929 Deferred Share Units 154,373 282 November 30, 2014 60,296,365 111,833 Issued pursuant to the Sunward Arrangement 43,116,312 22,851 Exercise of options 7,499 7 Exercise of Sunward Arrangement Options 347,999 177 Restricted Share Units 795,368 819 Deferred Share Units 232,878 353 November 30, 2015 104,796,421 136,040 Exercise of options 162,854 65 Restricted Share Units 108,399 34 Deferred Share Units 218,795 218 November 30, 2016, issued and outstanding 105,286,469 136,357 On April 30, 2012, under the NovaGold Arrangement, Trilogy committed to issue up to 6,181,352 20,685 3,447 312,195 Refer to note 4 for a description of Common Shares issued pursuant to the Sunward Arrangement. All Sunward Arrangement Options have been exercised or expired. (a) Stock options The Company has a stock option plan providing for the issuance of options with a rolling maximum number equal to 10 During the year ended November 30, 2016, 1,785,000 3,813,350 0.43 0.55 0.13 0.17 The fair value of the stock options recognized in the period has been estimated using the Black-Scholes option pricing model. Assumptions used in the pricing model for the period are as provided below. November 30, 2016 November 30, 2015 November 30, 2014 Risk-free interest rates 0.52 % 0.42-1.12 % 1.16 % Exercise price CDN$0.43 CDN$0.55 CDN$1.22 Expected life 3.0 years 3.0 years 3.0 years Expected volatility 59.4 % 56.8-59.5 % 60.2 % Expected dividends Nil Nil Nil The Company recognized a stock option payments charge of $ 0.4 0.7 0.5 As of November 30, 2016, there were 1,401,675 0.37 0.05 A summary of the Company’s stock option plan and changes during the year ended is as follows: November 30, 2016 Number of options Weighted average exercise Balance beginning of year 5,288,350 0.57 Granted 1,785,000 0.33 Exercised (422,199) 0.38 Forfeited (601,718) 0.58 Balance end of year 6,049,433 0.50 The following table summarizes information about the stock options outstanding at November 30, 2016. Outstanding Exercisable Unvested Range of price Number of Weighted Weighted Number of Weighted Number of $0.33 to $0.99 5,994,433 3.51 0.50 4,592,758 0.53 1,401,675 $1.00 to $1.47 55,000 1.42 1.47 55,000 1.47 - 6,049,433 3.49 0.50 4,647,758 0.55 1,401,675 The aggregate intrinsic value of vested share options (the market value less the exercise price) at November 30, 2016 was $ 0.6 0.1 (b) NovaGold Arrangement Options Under the NovaGold Arrangement, holders of NovaGold stock options received one option in Trilogy for every six options held in NovaGold (“NovaGold Arrangement Options”). All NovaGold Arrangement Options are vested and subject to NovaGold’s stock option plan. The options were fully expensed during the year ended November 30, 2014 and no further expense is recognized. A summary of the NovaGold Arrangement Options and changes during the year ended is as follows: November 30, 2015 Number of options Weighted average exercise Balance beginning of year 509,272 4.77 Forfeited (27,199) 4.68 Expired (169,878) 5.61 Balance end of year 312,195 4.28 The following table summarizes information about the NovaGold Arrangement Options outstanding at November 30, 2016. Outstanding and exercisable Range of price Number of outstanding Weighted average years Weighted average $2.75 to $3.99 49,998 0.33 2.91 $4.00 to $5.99 245,531 0.02 4.41 $6.00 to $6.48 16,666 0.50 6.45 312,195 0.09 4.28 The aggregate intrinsic value of vested NovaGold Arrangement Options (the market value less the exercise price) at November 30, 2016 was $nil (2015 - $nil, 2014 $nil). (c) Sunward Arrangement Options Under the Sunward Arrangement, each Sunward stock option outstanding was exchanged for a fully-vested Sunward Arrangement Option to purchase Trilogy Common Shares for a period of 90 days, such number and exercise price adjusted based on an exchange ratio of 0.3 2,505,000 During the year ended November 30, 2015, 347,999 188,000 142,000 2,157,001 0.01 (d) Restricted Share Units and Deferred Share Units The Company has a Restricted Share Unit Plan (“RSU Plan”) and a Non-Executive Director Deferred Share Unit Plan (“DSU Plan”) to provide long-term incentives to employees, officers and directors. The RSU Plan and DSU Plan may be settled in cash and/or Common Shares at the Company’s election with each RSU and DSU entitling the holder to receive one common share of the Company or equivalent value. All units are accounted for as equity-settled awards. On June 15, 2016, 75,000 164,582 On December 23, 2015, 600,000 A summary of the Company’s unit plans and changes during the year ended is as follows: Number of RSUs Number of DSUs Balance beginning of year - 904,603 Granted 600,000 239,582 Vested/paid (199,999) (218,795) Balance end of year 400,001 925,390 For the year ended November 30, 2016, Trilogy recognized a stock-based compensation charge of $ 0.3 0.1 0.4 (e) Share Purchase Warrants A summary of the Company’s warrants and changes during the year ended November 30, 2016 is as follows: Number of Warrants Weighted average Weighted average Balance beginning of year 6,521,740 2.60 1.60 Balance end of year 6,521,740 2.60 1.60 |